Sureshchandra S, Maheshwari R, Nowland T, Elhindi J, Rundjan L, DCruz D
Children (Basel). 2025; 12(2).
PMID: 40003274
PMC: 11854397.
DOI: 10.3390/children12020172.
Garunkstiene R, Levuliene R, Cekuolis A, Cerkauskiene R, Drazdiene N, Liubsys A
Medicina (Kaunas). 2025; 60(12.
PMID: 39768792
PMC: 11678379.
DOI: 10.3390/medicina60121910.
Contreras Chova F, Villanueva-Garcia A, Gonzalez-Boyero J, Campos-Martinez A, Blanca-Jover E, Jerez-Calero A
Cureus. 2024; 16(11):e73380.
PMID: 39659332
PMC: 11630059.
DOI: 10.7759/cureus.73380.
Barekatain B, Hamidipour S, Badiei Z, Farghadani M
Int J Prev Med. 2024; 15:55.
PMID: 39539572
PMC: 11559709.
DOI: 10.4103/ijpvm.ijpvm_236_23.
Guo H, Xie J, Yu X, Tian Y, Guan M, Wei J
Sci Rep. 2024; 14(1):23972.
PMID: 39397102
PMC: 11471846.
DOI: 10.1038/s41598-024-75191-w.
Evaluation of efficacy of oral calcium phosphate as an adjunct to standard-of-care regular phototherapy in cases of neonatal jaundice: a hospital-based double-blind, randomised, placebo-controlled trial.
Ghorui A, Chowdhry B, Manjhi P, Kumar P, Kumar C
BMJ Paediatr Open. 2024; 8(1).
PMID: 39395818
PMC: 11474712.
DOI: 10.1136/bmjpo-2024-002902.
Survey of vitamin D supplementation practices in extremely preterm infants.
Romero-Lopez M, Naik M, Holzapfel L, Salas A, Ahmad K, Rysavy M
Pediatr Res. 2024; .
PMID: 39191950
PMC: 11865359.
DOI: 10.1038/s41390-024-03514-8.
A Quality Improvement Project to Decrease Fractures Secondary to Metabolic Bone Disease of Prematurity.
Rau N, Monagle L, Fischer A
Pediatr Qual Saf. 2024; 9(4):e750.
PMID: 39077117
PMC: 11286248.
DOI: 10.1097/pq9.0000000000000750.
Randomized Controlled Trial of Enteral Vitamin D Supplementation (ViDES) in Infants <28 Weeks Gestational Age or <1000 Grams Birth Weight: Study Protocol.
Romero-Lopez M, Tyson J, Naik M, Pedroza C, Holzapfel L, Avritscher E
Res Sq. 2024; .
PMID: 38978597
PMC: 11230481.
DOI: 10.21203/rs.3.rs-4049246/v1.
Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity.
Llorente-Pelayo S, Docio P, Arriola S, Lavin-Gomez B, Garcia-Unzueta M, Ballesteros M
BMC Pediatr. 2024; 24(1):418.
PMID: 38951759
PMC: 11218264.
DOI: 10.1186/s12887-024-04897-7.
Randomized controlled trial of enteral vitamin D supplementation (ViDES) in infants <28 weeks gestational age or <1000 g birth weight: study protocol.
Romero-Lopez M, Tyson J, Naik M, Pedroza C, Holzapfel L, Avritscher E
Trials. 2024; 25(1):423.
PMID: 38943179
PMC: 11212399.
DOI: 10.1186/s13063-024-08274-8.
Analysis of clinical risk factors for metabolic bone disease of prematurity.
Liu X, Wang L, Qian M
Front Pediatr. 2024; 12:1345878.
PMID: 38818348
PMC: 11137184.
DOI: 10.3389/fped.2024.1345878.
Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology.
Baroncelli G, Comberiati P, Aversa T, Baronio F, Cassio A, Chiarito M
Front Endocrinol (Lausanne). 2024; 15:1383681.
PMID: 38706696
PMC: 11066174.
DOI: 10.3389/fendo.2024.1383681.
Incidence of metabolic bone disease in neonates under 32 gestational weeks at the Hospital Universitario de Santander in Colombia.
Ruiz E, Piamonte D, Gomez D, Diaz L, Perez L
Biomedica. 2024; 44(1):35-44.
PMID: 38648348
PMC: 11185430.
DOI: 10.7705/biomedica.6926.
High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants (HIDVID Trial): Study Protocol for a Randomized Controlled Study.
Paw D, Bokiniec R, Kolodziejczyk-Nowotarska A
Nutrients. 2024; 16(5).
PMID: 38474827
PMC: 10934590.
DOI: 10.3390/nu16050700.
Effect of early preventive supplementation with calcium and phosphorus on metabolic bone disease in premature infants.
Xu X, Ma H, Cheng S, Xue J
BMC Pediatr. 2024; 24(1):171.
PMID: 38459481
PMC: 10921623.
DOI: 10.1186/s12887-024-04654-w.
Human milk-derived versus bovine milk-derived fortifier use in very low birth weight infants: growth and vitamin D status.
Lavassani E, Tauber K, Cerone J, Ludke J, Munshi U
Front Pediatr. 2024; 12:1354683.
PMID: 38445079
PMC: 10913192.
DOI: 10.3389/fped.2024.1354683.
Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative.
Creed P, Huff K, Beard K, DiMeglio L, Stefanescu B
J Perinatol. 2024; 44(9):1369-1376.
PMID: 38321167
DOI: 10.1038/s41372-024-01892-9.
Neurodevelopment Outcomes in Very-Low-Birth-Weight Infants with Metabolic Bone Disease at 2 Years of Age.
Chen Y, Chang Y, Chen L, Lee C, Hsiao C, Chen J
Children (Basel). 2024; 11(1).
PMID: 38255389
PMC: 10814392.
DOI: 10.3390/children11010076.
Continuous versus intermittent bolus infusion of calcium in preterm infants receiving total parenteral nutrition: a randomized blind clinical trial.
Shiva S, Rezazadeh K, Amiraslanzadeh A, Mehramuz B, Yeganehdoost S, Mahallei M
BMC Pediatr. 2024; 24(1):35.
PMID: 38216920
PMC: 10785396.
DOI: 10.1186/s12887-023-04516-x.